» Articles » PMID: 34854577

Biomaterials-based Approaches for Cardiac Regeneration

Overview
Journal Korean Circ J
Date 2021 Dec 2
PMID 34854577
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The limited ability of cardiomyocytes to proliferate is a major cause of mortality and morbidity in cardiovascular diseases. There exist therapies for cardiac regeneration that are cell-based as well as that involve bioactive molecules. However, delivery remains one of the major challenges impeding such therapies from having clinical impact. Recent advancements in biomaterials-based approaches for cardiac regeneration have shown promise in clinical trials and animal studies in improving cardiac function, promoting angiogenesis, and reducing adverse immune response. This review will focus on current clinical studies of three contemporary biomaterials-based approaches for cardiac regeneration (extracellular vesicles, injectable hydrogels, and cardiac patches), remaining challenges and shortcomings to be overcome, and future directions for the use of biomaterials to promote cardiac regeneration.

Citing Articles

Hydrogels for Cardiac Tissue Regeneration: Current and Future Developments.

Holme S, Richardson S, Bella J, Pinali C Int J Mol Sci. 2025; 26(5).

PMID: 40076929 PMC: 11900105. DOI: 10.3390/ijms26052309.


Innovative approaches to boost mesenchymal stem cells efficacy in myocardial infarction therapy.

An C, Zhao Y, Guo L, Zhang Z, Yan C, Zhang S Mater Today Bio. 2025; 31:101476.

PMID: 39896290 PMC: 11787032. DOI: 10.1016/j.mtbio.2025.101476.


The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction.

Kamal N, A Heikal L, Abdallah O Drug Deliv Transl Res. 2025; .

PMID: 39833466 DOI: 10.1007/s13346-024-01763-y.


Use of Hydrogels in Regenerative Medicine: Focus on Mechanical Properties.

Carton F, Rizzi M, Canciani E, Sieve G, Di Francesco D, Casarella S Int J Mol Sci. 2024; 25(21).

PMID: 39518979 PMC: 11545898. DOI: 10.3390/ijms252111426.


Engineering extracellular vesicles for ROS scavenging and tissue regeneration.

Abdal Dayem A, Yan E, Do M, Kim Y, Lee Y, Cho S Nano Converg. 2024; 11(1):24.

PMID: 38922501 PMC: 11208369. DOI: 10.1186/s40580-024-00430-9.


References
1.
Gao L, Kupfer M, Jung J, Yang L, Zhang P, Sie Y . Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold. Circ Res. 2017; 120(8):1318-1325. PMC: 5392171. DOI: 10.1161/CIRCRESAHA.116.310277. View

2.
Shin Y, Shafranek R, Tsui J, Walcott J, Nelson A, Kim D . 3D bioprinting of mechanically tuned bioinks derived from cardiac decellularized extracellular matrix. Acta Biomater. 2020; 119:75-88. DOI: 10.1016/j.actbio.2020.11.006. View

3.
Pena B, Laughter M, Jett S, Rowland T, Taylor M, Mestroni L . Injectable Hydrogels for Cardiac Tissue Engineering. Macromol Biosci. 2018; 18(6):e1800079. PMC: 6166441. DOI: 10.1002/mabi.201800079. View

4.
Spadaccio C, Nappi F, De Marco F, Sedati P, Taffon C, Nenna A . Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction. J Cardiovasc Transl Res. 2017; 10(1):47-65. PMC: 5323505. DOI: 10.1007/s12265-016-9718-9. View

5.
Rao S, Zeymer U, Douglas P, Al-Khalidi H, White J, Liu J . Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction. J Am Coll Cardiol. 2016; 68(7):715-23. DOI: 10.1016/j.jacc.2016.05.053. View